Cell Lysis Market

Cell Lysis Market Size, Share & Trends Analysis Report by Product Type (Instruments, and Reagents & Consumables), by Cell Type (Mammalian Cells, Microbial Cells, and Plant Cells), by Application (Protein Isolation, Downstream Processing, Cell Organelle Isolation, and Nucleic Acid Isolation) and by End-User (Hospital & Diagnostic Labs, Academic and Research Institutes, and Pharmaceutical and Biotechnology Companies), Forecast Period (2022-2028)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2027137 | Category : Healthcare Information Technology | Delivery Format: /

Cell lysis market is anticipated to grow at a significant CAGR of 8.6% during the forecast period. The key factors contributing to the market growth include increasing cancer cases and the prevalence of several cancer across the globe. For instance, as per the data by GLOBOCAN 2020, an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths across the globe occurred in 2020. Under this female breast cancer and lung cancer were the most diagnostic cancer with a projected 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), and prostate (7.3%). Thus, with growing chronic and cardiovascular diseases testing, and the raising demand for more drugs attributed to it, there has been an increase in cell processing procedures, that in the turn is positively impacting the market growth. However, the commercial availability and reliability of tools that are used in cell disruption and lysis are factors that hamper the market growth.

Segmental Outlook 

The global cell lysis market is segmented based on product type, cell type, application, and end-user. Based on product type, the market is segmented into instruments, and reagents & consumables. Based on the cell type, the market is segmented into mammalian cells, microbial cells, and plant cells. Based on the application, the market is subdivided into protein isolation, downstream processing, cell organelle isolation, and nucleic acid isolation. Based on the end-user, the market is segmented into hospital & diagnostic labs, academic and research institutes, and pharmaceutical and biotechnology companies. Among the end, user segment pharmaceutical & biotechnology companies segment is anticipated to hold a prominent share in the market owing to the growing demand for biopharmaceuticals, high presence of companies that deal in molecular biology, and bioprocess techniques, and heavily employes in cell lysis protocols are such factors that drive segmental growth in cell lysis market growth.

Among the application segment, the protein isolation segment is predicted to hold a prominent share in the market due to the growing demand for efficient and rapid lysis techniques which extracts the proteins with minimal protein breakdown or oxidation are such factors that drive segmental growth further. For instance, in November 2021,  SCIENION & Cellenion, BICO companies launched proteoCHIP 12*16, which enables reproducible automated miniaturized single cell proteomics sample preparation. This solution was developed in partnership with the Research Institute of Molecular Pathology (IMP) and proteoCHIP, including cell lysis, protein digestion, peptide labeling, and quenching. This new solution extends Cellenion's unique platform for single-cell isolation and ultra-small volume dispensing. Furthermore, the increasing development of advanced bioprocessing reagents and equipment are other factors that boost the protein isolation segmental growth in the cell lysis market.

Regional Outlooks

The global cell lysis market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. North America region is estimated to hold a prominent share owing to the continuous growth of healthcare infrastructure in the region, and the rise in the patient population are contributing in cell lysis market growth during the forecast period.

Global Cell Lysis  Market Growth, by Region 2022-2028

Global Cell Lysis Market Growth, by Region

The Asia-Pacific Region is Fastest Growing in the Global Cell Lysis Market

The region is estimated to witness the fastest growth in the market owing to the growing interest of prominent players in emerging countries such as India, Japan, and China, high and large adoption of technological innovations, increasing research, and increased number of drug discoveries, and regulatory environment influence cell lysis market growth in the region. For instance, in May 2020, The Department of Biotechnology (DBT), started a project to sequence 1,000 SARS-CoV-2 genomes from samples for a better understanding of evolving COVID-19. This project collects samples across India for the study of emerging mutations in the virus and it also supports researchers' understanding how genetic variations in the human host. Additionally, rapid advancements in personalized cancer medicine, the growing prevalence of chronic diseases, and the developing and improving healthcare infrastructure in regional countries are anticipated to boost market growth further.

Market Players Outlook

The major companies serving the global cell lysis market include Beckman Coulter Inc., Bio-Rad Laboratories, Inc., Claremont BioSolutions, LLC., F. Hoffmann-La Roche, Miltenyi Biotec GmbH, Promega Corp., Qiagen NV, Thermo Fisher Scientific, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, geographical expansions, partnerships, product launches, and collaborations, to stay competitive in the market. For instance, in November 2020, Thermo Fisher Scientific and Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University entered into a collaboration. The collaboration was made to advance analytical capabilities and accelerate innovation across the biopharmaceutical industry in several fields such as personalized medicine, monoclonal antibodies, and gene & cell therapies. This new facility offer accuracy, precision, and reliability required to analyze complex molecules and develop robust, business need-driven, chromatography-based workflows.

The Report Covers

  • Market value data analysis of 2021 and forecast to 2028.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global cell lysis market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary

Current Industry Analysis and Growth Potential Outlook

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. ByRegion

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis

3.2. Bio-Rad Laboratories, Inc.

3.2.1. Overview

3.2.2. Financial Analysis 

3.2.3. SWOT Analysis

3.2.4. Recent Developments

3.3. F. Hoffmann-La Roche

3.3.1. Overview

3.3.2. Financial Analysis 

3.3.3. SWOT Analysis

3.3.4. Recent Developments

3.4. Promega Corp.

3.4.1. Overview

3.4.2. Financial Analysis 

3.4.3. SWOT Analysis

3.4.4. Recent Developments

3.5. Qiagen NV

3.5.1. Overview

3.5.2. Financial Analysis 

3.5.3. SWOT Analysis

3.5.4. Recent Developments

3.6. Thermo Fisher Scientific

3.6.1. Overview

3.6.2. Financial Analysis 

3.6.3. SWOT Analysis

3.6.4. Recent Developments

3.7. Key Strategy Analysis

4. Market Segmentation

4.1. Global Cell Lysis Market by Product Type

4.1.1. Instruments

4.1.2. Reagents

4.2. Global Cell Lysis Market by Cell Type

4.2.1. Mammalian Cells

4.2.2. Microbial Cells

4.2.3. Plant Cells

4.3. Global Cell Lysis Market by Application

4.3.1. Protein Isolation

4.3.2. Downstream Processing

4.3.3. Cell Organelle Isolation

4.3.4. Nucleic Acid Isolation

4.4. Global Cell Lysis Market by End User

4.4.1. Pharmaceutical and Biotechnology Companies

4.4.2. Hospital & Diagnostic Labs

4.4.3. Academic and Research Institutes

5. Regional Analysis

5.1. North America

5.1.1. US

5.1.2. Canada

5.2. Europe

5.2.1. UK

5.2.2. Germany

5.2.3. Italy

5.2.4. Spain

5.2.5. France

5.2.6. Rest of Europe 

5.3. Asia-Pacific

5.3.1. China

5.3.2. India

5.3.3. Japan

5.3.4. South Korea

5.3.5. Rest of Asia-Pacific 

5.4. Rest of the World

6. Company Profiles 

6.1. Beckman Coulter Inc.

6.2. Becton Dickinson & Co.

6.3. BioVision, Inc.

6.4. CELL BIOLOGICS

6.5. Cell Signaling Technology, Inc.

6.6. Claremont BioSolutions, LLC.

6.7. Covaris, LLC 

6.8. Genlantis Inc. 

6.9. Geno Technology, Inc.

6.10. Merck KGaA

6.11. Miltenyi Biotec GmbH

6.12. Microfluidics International Corp.

6.13. Qsonica L.L.C

6.14. PromoCell GmbH

6.15. NZYTech, Lda.

6.16. Parr Instrument Co.

6.17. ROCKLAND IMMUNOCHEMICALS, INC.

6.18. SPX FLOW, Inc.

6.19. STEMCELL Technologies Canada Inc. 

6.20. Takara Bio USA, Inc.

6.21. Tokyo Chemical Industry Co., Ltd.

1. GLOBAL CELL LYSIS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)

2. GLOBAL CELL LYSIS INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

3. GLOBAL CELL LYSIS REAGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

4. GLOBAL CELL LYSIS MARKET RESEARCH AND ANALYSIS BY CELL TYPES, 2021-2028 ($ MILLION)

5. GLOBAL MAMMALIAN CELL LYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

6. GLOBAL MICROBIAL CELL LYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

7. GLOBAL PLANT CELL LYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

8. GLOBAL CELL LYSIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

9. GLOBAL PROTEIN ISOLATION CELL LYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

10. GLOBAL DOWNSTREAM PROCESSING CELL LYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

11. GLOBAL CELL ORGANELLE ISOLATION CELL LYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

12. GLOBAL NUCLEIC ACID ISOLATION CELL LYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

13. GLOBAL CELL LYSIS MARKET RESEARCH AND ANALYSIS BY END USER, 2021-2028 ($ MILLION)

14. GLOBAL CELL LYSIS IN PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

15. GLOBAL CELL LYSIS IN HOSPITAL & DIAGNOSTIC LABS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

16. GLOBAL CELL LYSIS IN ACADEMIC AND RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

17. GLOBAL CELL LYSIS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)

18. NORTH AMERICAN CELL LYSIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)

19. NORTH AMERICAN CELL LYSIS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)

20. NORTH AMERICAN CELL LYSIS MARKET RESEARCH AND ANALYSIS BY CELL TYPE, 2021-2028 ($ MILLION)

21. NORTH AMERICAN CELL LYSIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

22. NORTH AMERICAN CELL LYSIS MARKET RESEARCH AND ANALYSIS BY END USER, 2021-2028 ($ MILLION)

23. EUROPEAN CELL LYSIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)

24. EUROPEAN CELL LYSIS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)

25. EUROPEAN CELL LYSIS MARKET RESEARCH AND ANALYSIS BY CELL TYPE, 2021-2028 ($ MILLION)

26. EUROPEAN CELL LYSIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

27. EUROPEAN CELL LYSIS MARKET RESEARCH AND ANALYSIS BY END USER, 2021-2028 ($ MILLION)

28. ASIA-PACIFIC CELL LYSIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)

29. ASIA-PACIFIC CELL LYSIS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)

30. ASIA-PACIFIC CELL LYSIS MARKET RESEARCH AND ANALYSIS BY CELL TYPE, 2021-2028 ($ MILLION)

31. ASIA-PACIFIC CELL LYSIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

32. ASIA-PACIFIC CELL LYSIS MARKET RESEARCH AND ANALYSIS BY END USER, 2021-2028 ($ MILLION)

33. REST OF THE WORLD CELL LYSIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)

34. REST OF THE WORLD CELL LYSIS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)

35. REST OF THE WORLD CELL LYSIS MARKET RESEARCH AND ANALYSIS BY CELL TYPE, 2021-2028 ($ MILLION)

36. REST OF THE WORLD CELL LYSIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)

37. REST OF THE WORLD CELL LYSIS MARKET RESEARCH AND ANALYSIS BY END USER, 2021-2028 ($ MILLION)

1. GLOBAL CELL LYSIS MARKET SHARE BY PRODUCT TYPE, 2021 VS 2028 (%)

2. GLOBAL CELL LYSIS INSTRUMENTS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

3. GLOBAL CELL LYSIS REAGENTS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

4. GLOBAL CELL LYSIS MARKET SHARE BY CELL TYPE, 2021 VS 2028 (%)

5. GLOBAL MAMMALIAN CELL LYSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

6. GLOBAL MICROBIAL CELL LYSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

7. GLOBAL PLANT CELL LYSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

8. GLOBAL CELL LYSIS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)

9. GLOBAL PROTEIN ISOLATION CELL LYSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

10. GLOBAL DOWNSTREAM PROCESSING CELL LYSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

11. GLOBAL CELL ORGANELLE ISOLATION  CELL LYSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

12. GLOBAL NUCLEIC ACID ISOLATION CELL LYSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

13. GLOBAL CELL LYSIS MARKET SHARE BY END USER, 2021 VS 2028 (%)

14. GLOBAL CELL LYSIS IN PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

15. GLOBAL CELL LYSIS IN HOSPITAL & DIAGNOSTIC LABS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

16. GLOBAL CELL LYSIS IN ACADEMIC AND RESEARCH INSTITUTES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

17. GLOBAL CELL LYSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

18. GLOBAL CELL LYSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)

19. US CELL LYSIS MARKET SIZE, 2021-2028 ($ MILLION)

20. CANADA CELL LYSIS MARKET SIZE, 2021-2028 ($ MILLION)

21. UK CELL LYSIS MARKET SIZE, 2021-2028 ($ MILLION)

22. FRANCE CELL LYSIS MARKET SIZE, 2021-2028 ($ MILLION)

23. GERMANY CELL LYSIS MARKET SIZE, 2021-2028 ($ MILLION)

24. ITALY CELL LYSIS MARKET SIZE, 2021-2028 ($ MILLION)

25. SPAIN CELL LYSIS MARKET SIZE, 2021-2028 ($ MILLION)

26. REST OF EUROPE CELL LYSIS MARKET SIZE, 2021-2028 ($ MILLION)

27. INDIA CELL LYSIS MARKET SIZE, 2021-2028 ($ MILLION)

28. CHINA CELL LYSIS MARKET SIZE, 2021-2028 ($ MILLION)

29. JAPAN CELL LYSIS MARKET SIZE, 2021-2028 ($ MILLION)

30. SOUTH KOREA CELL LYSIS MARKET SIZE, 2021-2028 ($ MILLION)

31. REST OF ASIA-PACIFIC CELL LYSIS MARKET SIZE, 2021-2028 ($ MILLION)

32. REST OF THE WORLD CELL LYSIS MARKET SIZE, 2021-2028 ($ MILLION)